Fluimukan 200 mg šumeće tablete
| Name | Fluimukan 200 mg šumeće tablete |
|---|---|
| Marketing Authorisation Number | HR-H-270848978 |
| Active Substance | acetilcistein |
| Composition | svaka šumeća tableta sadrži 200 mg acetilcisteina |
| Pharmaceutical Form | Šumeća tableta |
| Manufacturer | Hermes Pharma Ges.m.b.H., Wolfsberg, Austrija
Hermes Pharma GmbH, Wolfratshausen, Njemačka Salutas Pharma GmbH, Barleben, Njemačka |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 31.03.2023 |
| MA Period of Validity | 31.03.2028 |
| Classification Number | UP/I-530-09/22-01/168 |
| Registration Number | 381-12-01/171-23-08 |
| Prescription | Medicinal product not subject to medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | allowed |
| ATC Code | R05CB01 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
